In the U.S. approximately 14,000 children in the U. S. are diagnosed annually with cancer. Although 80 percent of these children will survive 5 years or more, cancer is the leading cause of death from disease in children.
Children’s Hospital of The King’s Daughters is one of more than 240 medical facilities participating in clinical trials through the Children’s Oncology Group (COG). COG is an international organization whose mission is to eliminate the personal, family and societal burden of cancer in children and adolescents by: preventing and curing childhood and adolescent cancer through scientific discovery and compassionate care, performing clinical and research trials, and conducting laboratory research.
The number of facilities participating in COG allows 90 percent of children diagnosed
with cancer access to state-of-the-art therapies offered by COG studies. Through its clinical trials, COG has increased the cure rate of childhood cancer to approximately 75 percent.
To find out more about COG and their supporting organization National Childhood Cancer Foundation, access the CureSearch website at www.curesearch.org.
CHKD's department of hematology/oncology is a member of the Children's Oncology Group (COG) and has approximately 70 COG studies open for enrollment.
The Children's Oncology Group develops and coordinates cancer research studies for over 220 member institutions, including cancer centers of all major universities and teaching hopsitals throughout North America.
Member facilities must undergo a thorough performance evaluation every three years and demonstrate competence, compliance and commitment to curing and preventing childhood and adolescent cancer through scientific discovery and compassionate care.
The National Cancer Institute of the National Institutes of Health oversees the research studies done in cooperation with the Children's Oncology Group.
Visit Children's Oncology Group for more information.
Our research office also provides support for studies that involve sickle cell and bleeding disorders patients. Many of these studies are national multi-cultural studies
sponsored by the National Institutes of Health (NIH). Before being registered for participation on any research study, the patient and family will be given a copy of the consent form, information about the study and given a chance to ask more questions. All patients who are registered in a research study must sign a consent form to take part in the study.
Consent to participate in any of our research studies is voluntary and the parent/family may choose to stop participating at any time by notifying us in writing. One of our hematology/oncology physicians will meet with the patient/family to discuss the study and explain the need for signed consents.
Currently, all research related paperwork, including consent forms and treatment plans, are reviewed by the Eastern Virginia Medical School Institutional Review Board. For more information, visit their website.